SLC26A4 and deafness: Despite the fact that both groups were implanted before 3.5 years of age, patients with GJB2 or SLC26A4 mutations, benefitting from the intact auditory pathway, have a better chance of developing satisfactory outcomes after implantation than those with unknown etiologies, where the causes of deafness are greatly heterogeneous.